arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ORTHOPEDIATRICS CORP

KIDS
$22.36 ▼ -0.45 (-1.97%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
42 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORTHOPEDIATRICS CORP faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $537.7M
Dividend Yield
Revenue Growth 15.4%
Op. Margin -5.8%
ROIC -0.9%
FCF / Share $-0.13
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity 0.31
info Valuation on last close. End-of-day price, Sep 23, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$70.51M
↑ +15.4%
Net Income Profit after all expenses
$-10.69M
— -0.3%
Operating Margin Operating profit as % of sales
-5.8%
↑ +58.9% 11th
FCF / Share Free cash flow per share
$-0.13
↑ +39.2%
Long-Term Debt Long-term obligations
$105.75M
↓ -0.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
12
Returns
33
Financial Health
33
Cash Quality
36

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 12 years · 42 quarters